4th Quarter - Report — PHARMACEUTICAL CARE MANAGEMENT ASSOCIAT… for PHARMACEUTICAL CARE MANAGEMENT ASSOCIAT… (2024)

Firm

PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

Client

PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION

Income

—

Expenses

$5,002,213

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits H.R.10545- December Continuing Resolution H.R.9096- Pharmacists Fight Back Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

Lobbyist	Covered position, as disclosed
JONATHAN M HEAFITZ	—
LUCIA LEBENS	—
JUAN CARLOS SCOTT	—
EMILY THREADGILL	—
JOCELYN WILES	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Bills named: H.R. 9096 (118th), H.R. 10545 (118th)

Health Issues HCR

Issues related to prescription drug coverage and pharmacy benefits Issues related to the prescription drug marketplace, patents, and competition Regulatory and proposed legislative changes to Medicare Part D and Medicaid prescription drug benefits H.R.10545- December Continuing Resolution H.R.9096- Pharmacists Fight Back Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

Lobbyist	Covered position, as disclosed
JONATHAN M HEAFITZ	—
LUCIA LEBENS	—
JUAN CARLOS SCOTT	—
EMILY THREADGILL	—
JOCELYN WILES	—

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 10545 (118th), H.R. 9096 (118th)

Pharmacy PHA

Issues related to pharmacy contracting with respect to drug pricing and pharmacy networks Regulatory and proposed legislative changes to Medicare Part D pharmacy contracting, pharmacy networks, and mail-service pharmacy H.R.10545 - December Continuing Resolution H.R. 9096 - Pharmacists Fight Back Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation

Lobbyist	Covered position, as disclosed
JONATHAN M HEAFITZ	—
LUCIA LEBENS	—
JUAN CARLOS SCOTT	—
EMILY THREADGILL	—
JOCELYN WILES	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Bills named: H.R. 9096 (118th), H.R. 10545 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.